# PEctin Rapid Fentanyl Efficacy Clinical Trial For pAin at Swallowing Undergoing radioTherapy

> **NCT01980498** · PHASE3 · WITHDRAWN · sponsor: **L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.**

## Conditions studied

- Predictable BTP at Swallowing in in Head/Neck Cancer Patients Undergoing Radiotherapy Already Receiving Opioid Therapy for Background Pain

## Interventions

- **DRUG:** Fentanyl pectin nasal spray (FPNS)
- **DRUG:** Physician choice-Usual care (PC-UC)

## Key facts

- **NCT ID:** NCT01980498
- **Lead sponsor:** L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-09
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2015-10-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01980498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01980498, "PEctin Rapid Fentanyl Efficacy Clinical Trial For pAin at Swallowing Undergoing radioTherapy". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT01980498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*